
NKMAX Co., Ltd. — Investor Relations & Filings
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주요사항보고서(유상증자결정) | 2026-02-19 | Korean | |
| 증권발행결과(자율공시) (제3자배정 유상증자) | 2026-02-02 | Korean | |
| 감자완료 | 2026-01-30 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2026-01-22 | Korean | |
| [기재정정]주요사항보고서(감자결정) | 2026-01-20 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2026-01-20 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 32538345 | [기재정정]주요사항보고서(유상증자결정) | 2026-02-19 | Korean | ||
| 13914971 | 증권발행결과(자율공시) (제3자배정 유상증자) | 2026-02-02 | Korean | ||
| 13753949 | 감자완료 | 2026-01-30 | Korean | ||
| 13192060 | [기재정정]주요사항보고서(유상증자결정) | 2026-01-22 | Korean | ||
| 13070232 | [기재정정]주요사항보고서(감자결정) | 2026-01-20 | Korean | ||
| 13070170 | [기재정정]주요사항보고서(유상증자결정) | 2026-01-20 | Korean | ||
| 12730609 | 주요사항보고서(유상증자결정) | 2026-01-15 | Korean | ||
| 12491740 | 최대주주변경을수반하는주식담보제공계약체결 | 2026-01-12 | Korean | ||
| 12191833 | [기재정정]주요사항보고서(유상증자결정) | 2026-01-07 | Korean | ||
| 12191536 | 기타경영사항(자율공시) (상장폐지결정등 효력정지 가처분신청) | 2026-01-07 | Korean | ||
| 12191533 | 기타시장안내 (정리매매 보류 관련) | 2026-01-07 | Korean | ||
| 12191532 | 주권매매거래정지 (투자자보호) | 2026-01-07 | Korean | ||
| 12190337 | 기타시장안내 (코스닥시장위원회 개최 결과 및 상장폐지 결정 안내) | 2026-01-06 | Korean | ||
| 12190328 | 주권매매거래정지해제 (상장폐지에 따른 정리매매 개시) | 2026-01-06 | Korean | ||
|
2025
1 filing
| |||||
| 12196476 | [기재정정]주요사항보고서(유상증자결정) | 2025-12-30 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NKMAX Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17727/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17727 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17727 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17727 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17727}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NKMAX Co., Ltd. (id: 17727)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.